Axillary adenopathy after COVID-19 vaccine in patients undergoing breast ultrasound

1. Grasselli G, Pesenti A, Cecconi M: Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 2020; 323: 1545–1546. Grasselli G Pesenti A Cecconi M : Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response . JAMA 2020 ; 323 : 1545 – 1546 . 10.1001/jama.2020.403132167538 Search in Google Scholar

2. Fleming TR, Nason M, Krause PR, Longini IM, Henao-Restrepo AM: COVID-19 vaccine trials: the potential for „hybrid” analyses. Clin Trials 2021; 18: 391–397. Fleming TR Nason M Krause PR Longini IM Henao-Restrepo AM : COVID-19 vaccine trials: the potential for „hybrid” analyses . Clin Trials 2021 ; 18 : 391 – 397 . 10.1177/17407745211018613831726834041932 Search in Google Scholar

3. Gringeri M, Mosini G, Battini V, Cammarata G, Guarnieri G, Carnovale C et al.: Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility. Hum Vaccin Immunother 2021; 17: 2969–2971. Gringeri M Mosini G Battini V Cammarata G Guarnieri G Carnovale C : Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility . Hum Vaccin Immunother 2021 ; 17 : 2969 – 2971 . 10.1080/21645515.2021.1917236817100334043934 Search in Google Scholar

4. Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M et al.: BNT162b2 vaccine induces neutralizing antibodies and polyspecific T cells in humans. Nature 2021; 595: 572–577. Sahin U Muik A Vogler I Derhovanessian E Kranz LM Vormehr M : BNT162b2 vaccine induces neutralizing antibodies and polyspecific T cells in humans . Nature 2021 ; 595 : 572 – 577 . 10.1038/s41586-021-03653-634044428 Search in Google Scholar

5. Skowronski DM, De Serres G: Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2021; 384: 1576–1577. Skowronski DM De Serres G : Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine . N Engl J Med 2021 ; 384 : 1576 – 1577 . 10.1056/NEJMc203624233596348 Search in Google Scholar

6. Cohen D, Hazut Krauthammer S, Cohen YC, Perry C, Avivi I, Herishanu Y et al.: Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy. Eur J Nucl Med Mol Imaging 2021; 48: 3540–3549. Cohen D Hazut Krauthammer S Cohen YC Perry C Avivi I Herishanu Y : Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy . Eur J Nucl Med Mol Imaging 2021 ; 48 : 3540 – 3549 . 10.1007/s00259-021-05389-x810651233966088 Search in Google Scholar

7. Cohen D, Krauthammer SH, Wolf I, Even-Sapir E: Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18 F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging 2021; 48: 1854–1863. Cohen D Krauthammer SH Wolf I Even-Sapir E : Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18 F]FDG PET-CT and relevance to study interpretation . Eur J Nucl Med Mol Imaging 2021 ; 48 : 1854 – 1863 . 10.1007/s00259-021-05314-2800389433774684 Search in Google Scholar

8. Eifer M, Tau N, Alhoubani Y, Kanana N, Domachevsky L, Shams J et al.: Covid-19 mRNA vaccination: age and immune status and its association with axillary lymph node PET/CT uptake. J Nucl Med 2021. Eifer M Tau N Alhoubani Y Kanana N Domachevsky L Shams J : Covid-19 mRNA vaccination: age and immune status and its association with axillary lymph node PET/CT uptake . J Nucl Med 2021 . 10.2967/jnumed.121.262194871718233893188 Search in Google Scholar

9. Hiller N, Goldberg SN, Cohen-Cymberknoh M, Vainstein V, Simanovsky N: Lymphadenopathy associated with the COVID-19 vaccine. Cureus 2021; 13: e13524. Hiller N Goldberg SN Cohen-Cymberknoh M Vainstein V Simanovsky N : Lymphadenopathy associated with the COVID-19 vaccine . Cureus 2021 ; 13 : 13524 . 10.7759/cureus.13524799436833786231 Search in Google Scholar

10. Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M: Lymphadenopathy following COVID-19 vaccination: imaging findings review. Acad Radiol 2021; 28: 058–1071. Keshavarz P Yazdanpanah F Rafiee F Mizandari M : Lymphadenopathy following COVID-19 vaccination: imaging findings review . Acad Radiol 2021 ; 28 : 058 – 1071 . 10.1016/j.acra.2021.04.007808821833985872 Search in Google Scholar

11. Tu W, Gierada DS, Joe BN: COVID-19 vaccination-related lymphadenopathy: what to be aware if. Radiol Imaging Cancer 2021; 3: e210038. Tu W Gierada DS Joe BN : COVID-19 vaccination-related lymphadenopathy: what to be aware if . Radiol Imaging Cancer 2021 ; 3 : e210038 . 10.1148/rycan.2021210038804917133874733 Search in Google Scholar

12. Vourtsis A, Berg WA: Breast density implications and supplemental screening. Eur Radiol 2019; 29: 1762–1777. Vourtsis A Berg WA : Breast density implications and supplemental screening . Eur Radiol 2019 ; 29 : 1762 – 1777 . 10.1007/s00330-018-5668-8642086130255244 Search in Google Scholar

13. Tagliafico AS, Mariscotti G, Valdora F, Durando M, Nori J, La Forgia D et al.: A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2). Eur J Cancer 2018; 104: 39–46. Tagliafico AS Mariscotti G Valdora F Durando M Nori J La Forgia D : A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2) . Eur J Cancer 2018 ; 104 : 39 – 46 . 10.1016/j.ejca.2018.08.02930316869 Search in Google Scholar

14. Tagliafico AS, Valdora F, Mariscotti G, Durando M, Nori J, La Forgia D et al.: An exploratory radiomics analysis on digital breast tomosynthesis in women with mammographically negative dense breasts. Breast 2018; 40: 92–96. Tagliafico AS Valdora F Mariscotti G Durando M Nori J La Forgia D : An exploratory radiomics analysis on digital breast tomosynthesis in women with mammographically negative dense breasts . Breast 2018 ; 40 : 92 – 96 . 10.1016/j.breast.2018.04.01629723697 Search in Google Scholar

15. Dialani V, James DF, Slanetz PJ: A practical approach to imaging the axilla. Insights Imaging 2015; 6: 217–229. Dialani V James DF Slanetz PJ : A practical approach to imaging the axilla . Insights Imaging 2015 ; 6 : 217 – 229 . 10.1007/s13244-014-0367-8437681825534139 Search in Google Scholar

16. Maxwell F, de Margerie Mellon C, Bricout M, Cauderlier E, Chapelier M, Albiter M et al.: Diagnostic strategy for the assessment of axillary lymph node status in breast cancer. Diagn Interv Imaging 2015; 96: 1089–1101. Maxwell F de Margerie Mellon C Bricout M Cauderlier E Chapelier M Albiter M : Diagnostic strategy for the assessment of axillary lymph node status in breast cancer . Diagn Interv Imaging 2015 ; 96 : 1089 – 1101 . 10.1016/j.diii.2015.07.00726372221 Search in Google Scholar

17. Patel T, Given-Wilson RM, Thomas V: The clinical importance of axillary lymphadenopathy detected on screening mammography: revisited. Clinical radiology. 2005; 60: 64–71. Patel T Given-Wilson RM Thomas V : The clinical importance of axillary lymphadenopathy detected on screening mammography: revisited . Clinical radiology. 2005 ; 60 : 64 – 71 . 10.1016/j.crad.2004.05.00715642295 Search in Google Scholar

18. Özütemiz C, Krystosek LA, Church AL, Chauhan A, Ellermann JM, Domingo-Musibay E et al.: Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients. Radiology 2021; 300: E296–E300. Özütemiz C Krystosek LA Church AL Chauhan A Ellermann JM Domingo-Musibay E : Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients . Radiology 2021 ; 300 : 296 – 300 . 10.1148/radiol.2021210275790907233625300 Search in Google Scholar

19. Becker AS, Perez-Johnston R, Chikarmane SA, Chen MM, El Homsi M, Feigin KN et al.: Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology Scientific Expert Panel. Radiology 2021; 300: E323–E327. Becker AS Perez-Johnston R Chikarmane SA Chen MM El Homsi M Feigin KN : Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology Scientific Expert Panel . Radiology 2021 ; 300 : 323 – 327 . 10.1148/radiol.2021210436790907133625298 Search in Google Scholar